Send the following on WhatsApp
Continue to ChatServier and OSE Immunotherapeutics complete enrollment in Sjögren’s syndrome trial on Labiotech.eu https://www.labiotech.eu/trends-news/servier-ose-immunotherapeutics-complete-enrollment-sjogrens-trial/